Understanding the genetic determinant of severity in viral diseases: a case of SARS-Cov-2 infection
- PMID: 38624552
- PMCID: PMC7773422
- DOI: 10.1186/s43042-020-00122-z
Understanding the genetic determinant of severity in viral diseases: a case of SARS-Cov-2 infection
Abstract
Background: Numerous research studies have identified specific human gene variants that affect enhanced susceptibility to viral infections. More recently is the current pandemic where the SARS-CoV-2 infection has shown a high degree of person-to-person clinical variability. A wide range of disease severity occurs in the patients' experiences, from asymptomatic cases, mild infections to serious life threatening conditions requiring admission into the intensive care unit (ICU).
Main body of the abstract: Although, it is generally reported that age and co-morbidities contribute significantly to the variations in the clinical outcome of the scourge of COVID-19, a hypothetical question of the possibility of genetic involvement in the susceptibility and severity of the disease arose when some unique severe outcomes were seen among young patients with no co-morbidity. The role human genetics play in clinical response to the viral infections is scarcely understood; however, several ongoing researches all around the world are currently focusing on possible genetic factors. This review reports the possible genetic factors that have been widely studied in defining the severity of viral infections using SARS-CoV-2 as a case study. These involve the possible involvements of ACE2, HLA, and TLR genes such as TLR7 and TLR3 in the presentation of a more severe condition.
Short conclusion: Understanding these variations could help to inform efforts to identify people at increased risk of infection outbreaks through genetic diagnosis of infections by locating disease genes or mutations that predispose patients to severe infection. This will also suggest specific targets for therapy and prophylaxis.
Keywords: Angiotensin-converting enzyme 2 (ACE2) gene; COVID-19; Coronavirus; Human leucocyte antigen (HLA) allele; SARS-CoV-2; Toll-like receptor (TLR).
© The Author(s) 2020.
Conflict of interest statement
Competing interestsThe authors declare no competing interests.
Figures


Similar articles
-
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10. J Pathol. 2020. PMID: 32418199 Free PMC article. Review.
-
Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity.Hum Genomics. 2020 Oct 22;14(1):40. doi: 10.1186/s40246-020-00290-4. Hum Genomics. 2020. PMID: 33092637 Free PMC article. Review.
-
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5. Trials. 2021. PMID: 33430924 Free PMC article.
-
The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy.Front Cell Infect Microbiol. 2021 Oct 22;11:753721. doi: 10.3389/fcimb.2021.753721. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34746028 Free PMC article. Review.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
Cited by
-
Hypotheses and facts for genetic factors related to severe COVID-19.World J Virol. 2021 Jul 25;10(4):137-155. doi: 10.5501/wjv.v10.i4.137. World J Virol. 2021. PMID: 34367930 Free PMC article. Review.
-
COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity.Immunogenetics. 2022 Aug;74(4):381-407. doi: 10.1007/s00251-022-01261-w. Epub 2022 Mar 29. Immunogenetics. 2022. PMID: 35348847 Free PMC article. Review.
-
ACE2 and TMPRSS2 SNPs as Determinants of Susceptibility to, and Severity of, a COVID-19 Infection.Br J Biomed Sci. 2022 Jan 12;79:10238. doi: 10.3389/bjbs.2021.10238. eCollection 2022. Br J Biomed Sci. 2022. PMID: 35996506 Free PMC article.
-
Routine Hematological Parameters May Be Predictors of COVID-19 Severity.Front Med (Lausanne). 2021 Jul 16;8:682843. doi: 10.3389/fmed.2021.682843. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34336889 Free PMC article.
-
Association of programmed cell death 1 (PD-1) gene polymorphism (rs10204525) with COVID-19 severity and mortality: A case-control study in the Iranian population.Int Immunopharmacol. 2023 Jun;119:110114. doi: 10.1016/j.intimp.2023.110114. Epub 2023 Mar 31. Int Immunopharmacol. 2023. PMID: 37172423 Free PMC article.
References
-
- World Health Organization (WHO), 2020(b). SARS (severe acute respiratory syndrome). https://www.who.int/ith/diseases/sars/en/
-
- World Health Organization (WHO), 2020(a). 10th November, 2020 Situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio.... Accessed November 13th, 2020.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous